Atherosclerotic renal artery stenosis (RAS) and coronary artery disease (CAD) arise from the same multiple risk factors. The purpose of this study was to assess the frequency of previously undiagnosed CAD in patients with angiographically confirmed RAS, by conducting coronary arteriography in the same setting. Of 57 consecutive patients referred for renal arteriography on clinical grounds during a 14-month period, 28 had no RAS and 6 had RAS, but previously documented CAD. Of the remainder 23 patients, 17 (74%; CI 56%-92%) had both RAS and CAD (7 single vessel, 4 two-vessel, and 7 multivessel disease). The clinical characteristics, such as age, blood pressure (BP) levels, signs of heart failure, were no different between those with and without CAD, although the 4 diabetic patients, the 4 patients with fundoscopic findings of grade III retinopathy, 11 of 14 with peripheral arterial disease, and 7 of 8 patients with prior stroke belonged in the CAD group. None developed complications as a result of the two consecutive procedures. The data suggest that in patients with RAS the frequency of silent CAD is high and cannot be predicted on clinical grounds alone, therefore coronary angiography should be routinely recommended in the same setting. Am
C
oronary artery disease (CAD) is one of the most important causes of death in patients with atherosclerotic renal artery stenosis (RAS). 1, 2 In those with bilateral RAS, the frequency of CAD is higher with a larger prevalence of multivessel disease and more severe lesions in the left main coronary artery. 3, 4 Likewise, a high prevalence of RAS has been reported in patients with documented CAD. [5] [6] [7] [8] For example, in 609 patients eligible for coronary angiography, Gross et al 8 performed routinely abdominal aortography for the detection of RAS. Of the 152 (25%) patients who had confirmed RAS, 143 (94%) had concomitant CAD. It has been suggested that patients in whom coronary arteriography is recommended should also undergo renal arteriography because of the high frequency of coexistence of these conditions. 9, 10 The profile of patients with RAS is similar to those with CAD, 2, [5] [6] [7] as both have multiple risk factors for the development of atherosclerosis in renal, coronary, and peripheral vascular beds. However, there are no studies where coronary angiography was performed in otherwise asymptomatic patients eligible for renal arteriography.
The purpose of this report was to evaluate the frequency of previously undiagnosed CAD in patients with suspected RAS referred for diagnostic renal arteriography, by conducting coronary angiography during the same procedure.
Methods
The study population consisted of patients attending the Renal Clinic of Botucatu Medical School between June 2004 and August 2005. All consecutive patients referred for renal arteriography on the basis of clinical characteristics (refractory hypertension on triple drug regimen, recent onset or aggravation of hypertension, unexplained decline in renal function) were asked to participate. All participants signed a written informed consent as approved by the Institutional Review Board for human studies. The algorithm used for investigation of RAS was as proposed by Bloch and Basile. 11 Exclusion criteria were severe uncontrolled hypertension, hemodynamic instability or cardiogenic shock, active infection, pulmonary thromboembolic events, hepatic failure, electrolyte or acid-base disturbance, acute renal failure, sustained or uncontrolled ventricular arrhythmia, heart failure class IV per New York Heart Association (NYHA), and history of allergic reaction to contrast media. Patients with known CAD (angina, prior myocardial infarct, or coronary artery revalscularization) did undergo coronary arteriography, if clinically indicated, but were excluded from the data analysis of this study.
Patients were admitted on the previous day of the procedure and were hydrated with normal saline infused at 1 mL/kg/h for 24 h before and 24 h after the procedure, and those with renal failure (serum creatinine Ն1.5 mg/ dL) received 600 mg oral N-acetyl-cysteine twice daily. 12 Serum creatinine was analyzed before, 2 days after, and 2 months after the procedure. Glomerular filtration rate (GFR) was calculated according to the Cockroft-Gault equation. 13 A nonionic contrast medium (Ioversol 320, Mallinckrodt, Inc., Raleigh, NC) of low osmolarity with a total volume of up to 140 mL for both procedures was used to minimize renal injury. 14 Renal artery stenosis was defined as presence of atherosclerotic stenotic lesion with more than 50% encroachment of the arterial lumen in a renal artery according to the examiner's visual analysis at the time of the procedure. Coronary arteriography was performed immediately after and quantification of arterial obstruction was done by two interventional cardiologists blinded as to the renal study results.
For evaluation the study population was divided into two groups according to the presence or absence of CAD and the groups were compared for clinical characteristics that could predict CAD.
Statistical Analysis
Results of parametric data were expressed as mean Ϯ standard deviation and nonparametric data as median followed by the interquartile interval. Discrete variables were expressed as percentage. The confidence interval of frequency of CAD in the studied sample was calculated. The clinical characteristics of groups with and without CAD were compared by t test for unpaired samples, MannWhitney or 2 when appropriate. Comparison of serum creatinine at three different points was made by ANOVA for repeated measurements. Statistical significance was accepted at P Ͻ .05.
Results
A total of 57 consecutive patients were submitted to renal angiography during this period. Twenty-eight had no RAS and six had previously confirmed CAD (myocardial infarct or coronary revascularization). The remainder 23, whose renal arteriography confirmed presence of RAS, were subsequently submitted to coronary angiography during the same setting and are the subjects of this study. Of these, 17 (74%; CI 56%-92%) had concurrent CAD in one or more coronary arteries. Seven (39%) had single vessel disease, three (18%) had two-vessel disease, and seven (39%) had multivessel disease.
Clinical characteristics of the patients and comparison between the two groups (ie, those with [n ϭ 17] and without CAD [n ϭ 6]) are shown in Table 1 . None of the characteristics were significantly different between groups, although patients with CAD tended to be older and to have more concurrent arterial diseases, such as stroke and peripheral vascular disease (PVD) with intermittent claudication. Of eight patients with RAS and prior stroke, 7 had previously unsuspected CAD and of 14 with PVD, 11 had also CAD. All four diabetics were also found to have CAD, as were all four patients with grade III retinopathy.
The changes in serum creatinine and GFR immediately after the procedure and 2 months later are shown in Table 2 . Patients with CAD had a significant increase in serum creatinine at 2 days, but it returned to baseline after 2 months, whereas those without CAD had no change, although overall, they had somewhat more advanced chronic renal failure. Of the 23 patients who had consecutive renal and coronary angiography in the same setting,
Discussion
It is well recognized that patients with multiple cardiovascular risk factors tend to develop significant atherosclerotic disease in the vascular beds of several target organs, including the coronary, cerebral, renal, and peripheral vasculature. Therefore, it should not be surprising that patients diagnosed with significant vascular disease in one organ are likely to have similar changes in other organs. [1] [2] [3] [4] [5] [6] [7] [8] In the current studies, we found that 74% of patients with significant RAS also had significant, previously undiagnosed CAD, although they had no symptoms of coronary insufficiency. If the additional six patients with previously known CAD are taken into account, the percentage of RAS patients with co-existing CAD reaches 79.3% (23 of 29). Although it is possible that in some cases-especially younger women with lower degrees of stenosis-the RAS might be attributable to fibromuscular dysplasia, the clinical characteristics of our patients and the arteriographic appearance of the stenotic lesions make this diagnosis highly unlikely.
No clinical predictor could separate the RAS patients with CAD from those without CAD. However, it is notable that all four diabetics and all four of those with accelerated hypertension (grade III retinopathy) also had CAD. Diabetics are notorious for having silent CAD, but it is of concern that so many nondiabetic patients with significant CAD, including several (Ͼ50%) with more than one affected vessel, were also asymptomatic. These findings suggest that CAD should be sought in RAS patients regardless of the presence or absence of cardiac symptomatology, especially as the severity of the two conditions seems to be highly correlated. 7, [15] [16] [17] It should be noted that this was a selected population attending a renal clinic, which explains the fact that all but one also had significant chronic renal failure. Renovascular disease is a frequent cause of chronic renal failure, accounting for 14% to 22% of end-stage renal disease. 18 -20 Chronic kidney disease in itself has long been recognized as a cardiovascular risk factor. Most of the increased mortality associated with it is attributable to cardiovascular causes. 2, [15] [16] [17] [18] [19] [20] [21] Yet the absence of symptoms of coronary insufficiency is intriguing. It is possible that the autonomic dysfunction, which frequently accompanies renal failure (as with diabetes), may account for the lack of CAD symptoms. This would suggest that coronary angiography should be routinely considered as a follow-up procedure in patients with angiographically confirmed RAS, as it is the best predictor of future events in such patients, 15, 16 regardless of presence or absence of symptoms of coronary insufficiency.
It is, of course, precisely this type of patient who is most at risk of adverse reactions to the contrast medium, which explains why clinicians are reluctant to have the two procedures performed consecutively in one setting. Our data indicate that with proper hydration and periprocedural care (with the use of a modest amount of nonionic contrast medium with low osmolarity), the risk is minimized. In both groups of patients the serum creatinine levels returned to baseline 2 months after the procedure, although some patients did have a transient increase after 2 days. Moreover, the percentage of those protocol patients who progressed to end-stage renal disease requiring dialysis (8.7%) was no different from that of a similar group of nonprotocol patients who only had renal arteriography (8.9%). This indicates that progression of the underlying renal disease was not attributable to insult from the additional amount of radio-opaque material.
In conclusion, our study suggests that patients with chronic renal failure and confirmed RAS have a very high probability of symptomatically silent, but clinically significant and largely undiagnosed CAD. Although this is a small study, it suggests that such patients should probably have routinely recommended coronary angiography after angiographic confirmation of RAS in a single setting, which would make it practical and cost effective. With proper periprocedural care, the risk of complications is minimized, even in patients with significantly reduced GFR, whereas the benefit of a documented diagnosis would be initiation of appropriate early treatment for prevention or reversal of an otherwise overlooked ischemic heart disease.
